183673-68-9 Usage
Description
1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN is a complex organic compound characterized by its unique molecular structure. It is a cyclic α,α-disubstituted amino acid, which is an essential building block for the synthesis of water-soluble, highly helical peptides. 1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN is presented as an off-white powder and is known for its significant role in the pharmaceutical and biotechnology industries due to its versatile applications.
Uses
Used in Pharmaceutical Industry:
1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the creation of novel drugs with improved properties, such as enhanced solubility, stability, and bioavailability.
Used in Peptide Synthesis:
In the field of peptide synthesis, 1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN serves as a crucial building block for the preparation of water-soluble, highly helical peptides. These peptides have a wide range of applications, including therapeutic uses, drug delivery, and as molecular probes for studying biological processes.
Used in Drug Delivery Systems:
1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN can be utilized in the development of advanced drug delivery systems. Its incorporation into these systems can enhance the targeting and release of therapeutic agents, leading to improved treatment outcomes and reduced side effects.
Used in Biotechnology Research:
1-T-BOC-PIPERIDINE-4-SPIRO-5'-[1',3'-BIS-T-BOC]-HYDANTOIN is also valuable in biotechnology research, where it can be employed to study the structure and function of proteins, as well as to develop new bioactive molecules with potential applications in various fields, such as agriculture, environmental science, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 183673-68-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,6,7 and 3 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 183673-68:
(8*1)+(7*8)+(6*3)+(5*6)+(4*7)+(3*3)+(2*6)+(1*8)=169
169 % 10 = 9
So 183673-68-9 is a valid CAS Registry Number.
183673-68-9Relevant articles and documents
A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF
-
Page/Page column 7, (2010/07/08)
The present invention relates to the novel antibacterial compounds having potent antibacterial activity as inhibitors of peptide deformylase. This invention further relates to pharmaceutically acceptable salts thereof, to processes for their preparation, and to pharmaceutical compositions containing them as an active ingredient.
N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors
Kiviranta, Paeivi H.,Leppaenen, Jukka,Rinne, Valtteri M.,Suuronen, Tiina,Kyrylenko, Olga,Kyrylenko, Sergiy,Kuusisto, Erkki,Tervo, Anu J.,Jaervinen, Tomi,Salminen, Antero,Poso, Antti,Wallen, Erik A.A.
, p. 2448 - 2451 (2008/02/03)
A series of N-(3-(4-hydroxyphenyl)-propenoyl)-amino acid tryptamides was based on a previously reported new SIRT2 inhibitor from our group, and it was designed to study if the molecular size of the compound could be reduced. The most potent compounds, N-(3-(4-hydroxyphenyl)-propenoyl)-2-aminoisobutyric acid tryptamide and N-(3-(4-hydroxyphenyl)-propenoyl)-l-alanine tryptamide, were equipotent, 30% smaller in molecular weight, and slightly more selective (SIRT2/SIRT1) than the parent compound.
Parallel solution- and solid-phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligands
Bleicher, Konrad H.,Wuethrich, Yves,De Boni, Maxime,Kolczewski, Sabine,Hoffmann, Torsten,Sleight, Andrew J.
, p. 2519 - 2522 (2007/10/03)
The combination of the 3,5-bis(trifluoromethyl)phenyl group with a spirohydantoin motive as a central scaffold was the basis for the design of a combinatorial library targeted towards the neurokinin-1 receptor. A solution- and solid-phase procedure is described and binding affinities of representative compounds presented.
